Synektik S.A. - Asset Resilience Ratio
Synektik S.A. (SNT) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2025)
This chart shows how Synektik S.A.'s Asset Resilience Ratio has changed over time. Check how strategically is Synektik S.A.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Synektik S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SNT market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0% |
| Short-term Investments | zł1.31K | 0.0% |
| Total Liquid Assets | zł1.31K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Synektik S.A. maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Synektik S.A. Industry Peers by Asset Resilience Ratio
Compare Synektik S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Medartis Holding AG
SW:MED |
Medical Devices | 0.00% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
Annual Asset Resilience Ratio for Synektik S.A. (2012–2025)
The table below shows the annual Asset Resilience Ratio data for Synektik S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.00% | zł1.31K ≈ $361.87 |
zł489.11 Million ≈ $134.61 Million |
-0.27pp |
| 2023-12-31 | 0.27% | zł802.49K ≈ $220.86K |
zł299.92 Million ≈ $82.54 Million |
-0.23pp |
| 2022-12-31 | 0.50% | zł1.18 Million ≈ $324.29K |
zł236.48 Million ≈ $65.08 Million |
+3.52pp |
| 2021-12-31 | -3.02% | zł-4.83 Million ≈ $-1.33 Million |
zł159.69 Million ≈ $43.95 Million |
+1.75pp |
| 2020-12-31 | -4.77% | zł-6.76 Million ≈ $-1.86 Million |
zł141.61 Million ≈ $38.97 Million |
-1.32pp |
| 2019-12-31 | -3.46% | zł-4.33 Million ≈ $-1.19 Million |
zł125.10 Million ≈ $34.43 Million |
-3.07pp |
| 2018-12-31 | -0.39% | zł-421.39K ≈ $-115.97K |
zł108.59 Million ≈ $29.88 Million |
-0.39pp |
| 2016-12-31 | 0.00% | zł-1.50K ≈ $-412.82 |
zł90.75 Million ≈ $24.98 Million |
+0.08pp |
| 2015-12-31 | -0.08% | zł-85.07K ≈ $-23.41K |
zł104.40 Million ≈ $28.73 Million |
-0.08pp |
| 2014-12-31 | 0.00% | zł-1.50K ≈ $-412.82 |
zł106.79 Million ≈ $29.39 Million |
-0.83pp |
| 2012-12-31 | 0.83% | zł511.96K ≈ $140.90K |
zł61.56 Million ≈ $16.94 Million |
-- |
About Synektik S.A.
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more